What is she best known for?
The fields of study she is best known for:
The scientist’s investigation covers issues in Cell biology, Transforming growth factor beta, Carcinogenesis, Transforming growth factor, beta 3 and Transforming growth factor.
Her Cell biology research is multidisciplinary, incorporating perspectives in Internal medicine and Endocrinology.
In her study, Kinase, Molecular biology and Kinase activity is strongly linked to Cancer cell, which falls under the umbrella field of Transforming growth factor beta.
The Carcinogenesis study combines topics in areas such as Tumor progression, Cancer research and Carcinoma.
Her Transforming growth factor, beta 3 study combines topics from a wide range of disciplines, such as TGF beta signaling pathway, TGF beta receptor 2 and TGF beta 1.
Rosemary J. Akhurst has included themes like Vasculogenesis and Immunology in her TGF beta signaling pathway study.
Her most cited work include:
- TGF-beta signaling in tumor suppression and cancer progression. (1950 citations)
- Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice (923 citations)
- Targeting the TGFβ signalling pathway in disease. (890 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Transforming growth factor, Cancer research, Cell biology, Transforming growth factor beta and Genetics.
Her research integrates issues of DNA damage, Receptor, Autocrine signalling, In situ hybridization and ITGB8 in her study of Transforming growth factor.
Her work carried out in the field of Cancer research brings together such families of science as Carcinogenesis, Cancer, Epithelial–mesenchymal transition and Signal transduction.
Her studies in Cell biology integrate themes in fields like Endothelial stem cell, Transforming growth factor, beta 3, Internal medicine and Endocrinology.
The various areas that Rosemary J. Akhurst examines in her Transforming growth factor beta study include Immunology, TGF beta signaling pathway, Molecular biology, Knockout mouse and Metastasis.
Her Immunology research incorporates themes from Yolk sac and Haematopoiesis.
She most often published in these fields:
- Transforming growth factor (34.58%)
- Cancer research (32.71%)
- Cell biology (36.45%)
What were the highlights of her more recent work (between 2012-2021)?
- Cancer research (32.71%)
- Transforming growth factor (34.58%)
- Cancer (14.95%)
In recent papers she was focusing on the following fields of study:
Cancer research, Transforming growth factor, Cancer, Cell biology and Signal transduction are her primary areas of study.
Her Cancer research study integrates concerns from other disciplines, such as Genetic variation and Immunotherapy.
Her research in Transforming growth factor intersects with topics in Stromal cell and ITGB8.
Her Cancer study also includes fields such as
- Immune system that intertwine with fields like Cervical cancer, Cell and Clinical significance,
- Stem cell that intertwine with fields like Cancer cell, Carcinoma, Cell culture and Carcinogenesis.
Rosemary J. Akhurst has researched Cell biology in several fields, including Endothelial stem cell, Epithelial–mesenchymal transition, Reprogramming and Autocrine signalling.
Her primary area of study in Signal transduction is in the field of Transforming growth factor beta.
Between 2012 and 2021, her most popular works were:
- Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. (70 citations)
- Targeting TGF-β Signaling for Therapeutic Gain (66 citations)
- Excessive vascular sprouting underlies cerebral hemorrhage in mice lacking αVβ8-TGFβ signaling in the brain (60 citations)
In her most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Transforming growth factor, Cancer research, Cancer, Signal transduction and Immunotherapy.
Her Transforming growth factor research focuses on Transforming growth factor beta in particular.
Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer stem cell, Stem cell, Blockade, Transmembrane protein and PI3K/AKT/mTOR pathway.
Her Cancer research incorporates elements of Fibrosis, Receptor and Cell type.
Her Signal transduction research is multidisciplinary, relying on both SUPERFAMILY, Tgfβ superfamily and Bioinformatics.
Her biological study spans a wide range of topics, including Epithelial–mesenchymal transition and T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
